Funding Details
- Awarder
- Inbox
- Date Award
- May 21, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Founding Year
- 2020
- Traction
- AltruBio has successfully raised funding rounds, shifted its focus to immunology, and has a drug in mid-stage testing for ulcerative colitis.
- Founders
- Judy Chou, Jesse Hall, Jeroen Grasman
- Company Description
- AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.
- Market
- Immunology
- Location
-
San Francisco,
US
- Coinvestors
- BVF Partners, RA Capital Management, Cormorant Asset Management
Links